Navigation Links
Marijuana Doctors Offers Physicians Unique Patient Reporting Tool for Medical Cannabis Patients
Date:8/14/2014

New York, New York (PRWEB) August 14, 2014

Recently, it has come to the attention of Marijuana Doctors (a subsidiary to the Medical Cannabis Network) that many opponents of legalized or reformed medical marijuana statutes, in states across the nation are finding fault with proposed legislation and regulations. These opponents attempt to maintain their claims on the grounds that there is not enough control or transparency given to the medical professional, in most cases physicians, that issue the patients recommendation.

Particularly, the Florida Medical Association has voiced its stance against Amendment 2, the ballot amendment that will be presented to Florida voters in November legalizing medical marijuana. In a recent statement issued by the FMA, they claimed that the lack of physician oversight, or physician monitoring of a patients cannabis usage is one reason they feel the program as designed will have unintended public health consequences. Additionally the FMA claims that the current version of Amendment 2 does not require marijuana specific training for medical professionals who have been traditionally taught that this was an unacceptable form of medicine. “The lack of clear definitions in the amendment would allow health-care providers with absolutely no training in the ordering of controlled substances, to order medical marijuana.” Dr. Pillersdorf, the president of the FMA said in its released statement.

MarijuanaDoctors.com, a flagship brand of the Medical Cannabis Network has developed the necessary technology to enable physicians to properly monitor their patient’s marijuana usage. In lieu of federal infrastructure, MarijuanaDoctors.com offers physicians the ability to understand how medical cannabis affects individual patients in regards to their specific disease or debilitating condition. The mobile app, coined “Titration Tracker” by the Medical Cannabis Network, allows patients to report and send their medical marijuana usage data directly to their attending physicians. By allowing and helping physicians to establish a medical understanding of the effects of this treatment we believe medical marijuana can gain a stronger foothold within the traditionally conservative medical community.

Patients using the “Titration Tracker” can input critical data fields such as disease, current prescription medication used, symptoms, symptom severity, form of medicine used (flower, concentrate, edible, tincture, topical), dosage use, strain used, and date of usage. This collective input of information allows physicians to get a clearer understanding on the effects that marijuana has on their patients. In conjunction with this innovative technology and quintessential work flow that helps ensure state compliance, MarijuanaDoctors.com has created and distributed a 30-page educational guide for physicians looking to better understand their specific state laws and the current research available on the topic.

By being proactive and understanding current medical protocols the Medical Cannabis Network was able to develop a system that has solved the problems many opponents to cannabis, such as the Florida Medical Association, have stated exist in currently proposed medical marijuana legislation. Current federal scheduling deems cannabis to have no established value, these conflicts directly with the laws and statutes of 23 states in addition to our nation’s capitol who have said otherwise. By encouraging physicians and patients to use our software MarijuanaDoctors.com aims to be the leaders in helping to establish medical understanding of marijuana amongst a generation of open minded and innovative physicians.

For additional information on how physicians and patients can use the “Titration Tracker” please contact patient support @ (888)392-9772 extension 1. For further information on how to receive the free educational guide for physicians please contact John Nicolazzo @ (305)728-4858

Read the full story at http://www.prweb.com/releases/2014/08/prweb12093106.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Marijuana Industry Website GreenRushReview.com Introduces Company Profiles and Press Room Sections to Website
2. Oaksterdam University to Host “Grow Medicine” Marijuana Training Featuring Rhode Island Native, Medical Marijuana Expert and Activist Todd McCormick on August 15 to 17
3. Marijuana Doctors Backs The New York Times
4. Chicago Begins Accepting Online Medical Marijuana Applications
5. Cannascan® Solves Patient Verification problem for Medical Marijuana patients and Law Enforcement in Massachusetts
6. Colorado Braces Itself for New Medical Marijuana Guidelines and Regulations
7. First Major Florida Marijuana Business Seminar Set For August 9th 2014
8. CADCA Responds to New York Times Editorial Board's Call for Marijuana Legalization
9. Marijuana Edibles Sales Show Growth in Market
10. Louisiana Recognizes Dangers of Synthetic Marijuana
11. Washington D.C. Decriminalizes Marijuana
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The ... from the NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart ... granted to organizations that have excellent programs for the delivery and improvement of ...
(Date:3/23/2017)... ... March 23, 2017 , ... March 23, 2017 - ... to easily reprint customer invoices, bills, statements and other correspondence when they have ... needed to retrieve and print the documents and batch them for efficient handling. ...
(Date:3/23/2017)... OR (PRWEB) , ... March 23, 2017 , ... Sharon ... Water, Global Climate Change and Your Health on VoiceAmerica, recently talked on her program ... she also used the occasion to remind listeners of an important distinction. World Water ...
(Date:3/23/2017)... ... March 23, 2017 , ... Corra Group is ... competitive pricing. Verisys through its FACIS and other services maintains the ... actions. , “We are delighted to be able to offer these various products ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, 2017 ... will the new EU MDR language change the way manufacturers approach CERs? ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017  Cornerstone Pharmaceuticals, Inc., a ... milestone today.  Following successful End-of-Phase I (EOP1) ... and Drug Administration (FDA), the Company has ... path forward to conduct pivotal trials of ... acute myeloid leukemia (AML) and pancreatic cancer. ...
(Date:3/23/2017)... March 23, 2017 Piramal ... Limited, anuncia el nombramiento de Stuart E. ... plataforma de servicios integrados completa para su base ... cargo clave en el crecimiento y ejecución de ... responsable de impulsar todas las actividades de desarrollo ...
(Date:3/23/2017)... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... a Phase 1 study of MM-310 in solid tumors. ... novel taxane and targets the EphA2 receptor, a protein ... major tumor types, including prostate, ovarian, bladder, gastric, pancreatic ... study is an important step in evaluating MM-310,s safety ...
Breaking Medicine Technology: